Janux Therapeutics, Inc. (JANX) Misses Q1 EPS by 1c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q1 EPS of ($0.38), $0.01 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• Freedom Broker Starts Holley (HLLY) at Buy
• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Planet Fitness operator United PF Holdings in debt-for-equity talks with lenders - Bloomberg